Mitochondria-Targeted Antioxidants Protect Against Amyloid-β Toxicity in Alzheimer's Disease Neurons
Open Access
- 3 June 2010
- journal article
- Published by SAGE Publications in Journal of Alzheimer's Disease
- Vol. 20 (s2) , S609-S631
- https://doi.org/10.3233/jad-2010-100564
Abstract
The purpose of our study was to investigate the effects of the mitochondria-targeted antioxidants, MitoQ and SS31, and the anti-aging agent resveratrol on neurons from a mouse model (Tg2576 line) of Alzheimer's disease (AD) and on mouse neuroblastomaKeywords
This publication has 67 references indexed in Scilit:
- Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease miceProceedings of the National Academy of Sciences, 2009
- Coupling of the NMDA receptor to neuroprotective and neurodestructive eventsBiochemical Society Transactions, 2009
- Mitochondria Targeted Peptides Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine NeurotoxicityAntioxidants and Redox Signaling, 2009
- Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's diseaseNature Medicine, 2008
- Dynamin-Like Protein 1 Reduction Underlies Mitochondrial Morphology and Distribution Abnormalities in Fibroblasts from Sporadic Alzheimer's Disease PatientsThe American Journal of Pathology, 2008
- The role of FoxO in the regulation of metabolismOncogene, 2008
- Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer’s disease pathologyActa Neuropathologica, 2008
- Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic CationsAnnual Review of Pharmacology and Toxicology, 2007
- PGC-1α: a key regulator of energy metabolismAdvances in Physiology Education, 2006
- Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegenerationCell Metabolism, 2006